AgingResearch.NewsJoin free

Phase 1Completed

Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human

A Single-center, Open-label, Fixed-sequence, Self-controlled Pharmacokinetics Study of Metformin and HRS-7535 in Healthy Subjects

Sponsor
Shandong Suncadia Medicine Co., Ltd. (Industry)
Enrolment
18 enrolled
Conditions
Diabetes
Interventions
HRS-7535 tablets; Metformin Hydrochloride Extended-release Tablets; Metformin Hydrochloride Tablets
Ages
adults
Registry
NCT06727838

Full record on ClinicalTrials.gov

From the registry

This study was a single-center, open, fixed-sequence, self-controlled trial design conducted in healthy subjects.

Primary outcomes

  • Maximum plasma concentration (Cmax)
  • Area under the plasma concentration-time curve from time zero to the time of last quantifiable analyte concentration (AUC0-t)
  • Area under the plasma concentration-time curve from time zero extrapolated to infinity (AUC0-∞)

History

  1. Last registry update

  2. Primary completion

  3. Started

  4. Registered